亚洲天堂黄片A片,好吊色欧美一区二区三区

內(nèi)容概括

A contract manufacturing organization (CMO), sometimes called a contract development and manufacturing organization (CDMO), is a company that serves other companies in the pharmaceutical industry on a contract basis to provide comprehensive services from drug development through drug manufacturing. A contract research organization (CRO) is an organization that provides support to the pharmaceutical, biotechnology, and medical device industries in the form of research services outsourced on a contract basis.Scope of the Report:
This report studies the Biopharmaceutical CMO & CRO market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the Biopharmaceutical CMO & CRO market by product type and applications/end industries.
U.S is estimated to have the largest number of biomanufacturing facilities, which in turn, has resulted in the largest share of North America region. Moreover, presence of effective regulatory bodies to monitor the overall biopharmaceutical development process to ensure the product safety and efficacy is driving the regional market of North America.
The global Biopharmaceutical CMO & CRO market is valued at xx million USD in 2017 and is expected to reach xx million USD by the end of 2023, growing at a CAGR of xx% between 2017 and 2023.
The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.
North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Biopharmaceutical CMO & CRO.
Europe also play important roles in global market, with market size of xx million USD in 2017 and will be xx million USD in 2023, with a CAGR of xx%.Market Segment by Companies, this report covers
Lonza
Boehringer Ingelheim GmbH
Rentschler Biotechnologie GmbH
Inno Biologics Sdn Bhd
JRS Pharma
BIOMEVA GmbH
ProBioGen
FUJIFILM Diosynth Biotechnologies U.S.A., Inc.
TOYOBO CO., LTD
Samsung BioLogics
Patheon
CMC Biologics
Binex Co., Ltd.
AbbVie Inc.
WuXi BiologicsMarket Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)Market Segment by Type, covers
Mammalian
Non-mammalianMarket Segment by Applications, can be divided into
Contract Manufacturing
Contract Research

報(bào)告目錄

1 Biopharmaceutical CMO & CRO Market Overview

1.1 Product Overview and Scope of Biopharmaceutical CMO & CRO

1.2 Classification of Biopharmaceutical CMO & CRO by Types

1.2.1 Global Biopharmaceutical CMO & CRO Revenue Comparison by Types (2017-2023)

1.2.2 Global Biopharmaceutical CMO & CRO Revenue Market Share by Types in 2017

1.2.3 Mammalian

1.2.4 Non-mammalian

1.3 Global Biopharmaceutical CMO & CRO Market by Application

1.3.1 Global Biopharmaceutical CMO & CRO Market Size and Market Share Comparison by Applications (2013-2023)

1.3.2 Contract Manufacturing

1.3.3 Contract Research

1.4 Global Biopharmaceutical CMO & CRO Market by Regions

1.4.1 Global Biopharmaceutical CMO & CRO Market Size (Million USD) Comparison by Regions (2013-2023)

1.4.1 North America (USA, Canada and Mexico) Biopharmaceutical CMO & CRO Status and Prospect (2013-2023)

1.4.2 Europe (Germany, France, UK, Russia and Italy) Biopharmaceutical CMO & CRO Status and Prospect (2013-2023)

1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Biopharmaceutical CMO & CRO Status and Prospect (2013-2023)

1.4.4 South America (Brazil, Argentina, Colombia) Biopharmaceutical CMO & CRO Status and Prospect (2013-2023)

1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Biopharmaceutical CMO & CRO Status and Prospect (2013-2023)

1.5 Global Market Size of Biopharmaceutical CMO & CRO (2013-2023)

2 Manufacturers Profiles

2.1 Lonza

2.1.1 Business Overview

2.1.2 Biopharmaceutical CMO & CRO Type and Applications

2.1.3 Lonza Biopharmaceutical CMO & CRO Revenue, Gross Margin and Market Share (2016-2017)

2.2 Boehringer Ingelheim GmbH

2.2.1 Business Overview

2.2.2 Biopharmaceutical CMO & CRO Type and Applications

2.2.3 Boehringer Ingelheim GmbH Biopharmaceutical CMO & CRO Revenue, Gross Margin and Market Share (2016-2017)

2.3 Rentschler Biotechnologie GmbH

2.3.1 Business Overview

2.3.2 Biopharmaceutical CMO & CRO Type and Applications

2.3.3 Rentschler Biotechnologie GmbH Biopharmaceutical CMO & CRO Revenue, Gross Margin and Market Share (2016-2017)

2.4 Inno Biologics Sdn Bhd

2.4.1 Business Overview

2.4.2 Biopharmaceutical CMO & CRO Type and Applications

2.4.3 Inno Biologics Sdn Bhd Biopharmaceutical CMO & CRO Revenue, Gross Margin and Market Share (2016-2017)

2.5 JRS Pharma

2.5.1 Business Overview

2.5.2 Biopharmaceutical CMO & CRO Type and Applications

2.5.3 JRS Pharma Biopharmaceutical CMO & CRO Revenue, Gross Margin and Market Share (2016-2017)

2.6 BIOMEVA GmbH

2.6.1 Business Overview

2.6.2 Biopharmaceutical CMO & CRO Type and Applications

2.6.3 BIOMEVA GmbH Biopharmaceutical CMO & CRO Revenue, Gross Margin and Market Share (2016-2017)

2.7 ProBioGen

2.7.1 Business Overview

2.7.2 Biopharmaceutical CMO & CRO Type and Applications

2.7.3 ProBioGen Biopharmaceutical CMO & CRO Revenue, Gross Margin and Market Share (2016-2017)

2.8 FUJIFILM Diosynth Biotechnologies U.S.A., Inc.

2.8.1 Business Overview

2.8.2 Biopharmaceutical CMO & CRO Type and Applications

2.8.3 FUJIFILM Diosynth Biotechnologies U.S.A., Inc. Biopharmaceutical CMO & CRO Revenue, Gross Margin and Market Share (2016-2017)

2.9 TOYOBO CO., LTD

2.9.1 Business Overview

2.9.2 Biopharmaceutical CMO & CRO Type and Applications

2.9.3 TOYOBO CO., LTD Biopharmaceutical CMO & CRO Revenue, Gross Margin and Market Share (2016-2017)

2.10 Samsung BioLogics

2.10.1 Business Overview

2.10.2 Biopharmaceutical CMO & CRO Type and Applications

2.10.3 Samsung BioLogics Biopharmaceutical CMO & CRO Revenue, Gross Margin and Market Share (2016-2017)

2.11 Patheon

2.11.1 Business Overview

2.11.2 Biopharmaceutical CMO & CRO Type and Applications

2.11.3 Patheon Biopharmaceutical CMO & CRO Revenue, Gross Margin and Market Share (2016-2017)

2.12 CMC Biologics

2.12.1 Business Overview

2.12.2 Biopharmaceutical CMO & CRO Type and Applications

2.12.3 CMC Biologics Biopharmaceutical CMO & CRO Revenue, Gross Margin and Market Share (2016-2017)

2.13 Binex Co., Ltd.

2.13.1 Business Overview

2.13.2 Biopharmaceutical CMO & CRO Type and Applications

2.13.3 Binex Co., Ltd. Biopharmaceutical CMO & CRO Revenue, Gross Margin and Market Share (2016-2017)

2.14 AbbVie Inc.

2.14.1 Business Overview

2.14.2 Biopharmaceutical CMO & CRO Type and Applications

2.14.3 AbbVie Inc. Biopharmaceutical CMO & CRO Revenue, Gross Margin and Market Share (2016-2017)

2.15 WuXi Biologics

2.15.1 Business Overview

2.15.2 Biopharmaceutical CMO & CRO Type and Applications

2.15.3 WuXi Biologics Biopharmaceutical CMO & CRO Revenue, Gross Margin and Market Share (2016-2017)

3 Global Biopharmaceutical CMO & CRO Market Competition, by Players

3.1 Global Biopharmaceutical CMO & CRO Revenue and Share by Players (2013-2018)

3.2 Market Concentration Rate

3.2.1 Top 5 Biopharmaceutical CMO & CRO Players Market Share

3.2.2 Top 10 Biopharmaceutical CMO & CRO Players Market Share

3.3 Market Competition Trend

4 Global Biopharmaceutical CMO & CRO Market Size by Regions

4.1 Global Biopharmaceutical CMO & CRO Revenue and Market Share by Regions

4.2 North America Biopharmaceutical CMO & CRO Revenue and Growth Rate (2013-2018)

4.3 Europe Biopharmaceutical CMO & CRO Revenue and Growth Rate (2013-2018)

4.4 Asia-Pacific Biopharmaceutical CMO & CRO Revenue and Growth Rate (2013-2018)

4.5 South America Biopharmaceutical CMO & CRO Revenue and Growth Rate (2013-2018)

4.6 Middle East and Africa Biopharmaceutical CMO & CRO Revenue and Growth Rate (2013-2018)

5 North America Biopharmaceutical CMO & CRO Revenue by Countries

5.1 North America Biopharmaceutical CMO & CRO Revenue by Countries (2013-2018)

5.2 USA Biopharmaceutical CMO & CRO Revenue and Growth Rate (2013-2018)

5.3 Canada Biopharmaceutical CMO & CRO Revenue and Growth Rate (2013-2018)

5.4 Mexico Biopharmaceutical CMO & CRO Revenue and Growth Rate (2013-2018)

6 Europe Biopharmaceutical CMO & CRO Revenue by Countries

6.1 Europe Biopharmaceutical CMO & CRO Revenue by Countries (2013-2018)

6.2 Germany Biopharmaceutical CMO & CRO Revenue and Growth Rate (2013-2018)

6.3 UK Biopharmaceutical CMO & CRO Revenue and Growth Rate (2013-2018)

6.4 France Biopharmaceutical CMO & CRO Revenue and Growth Rate (2013-2018)

6.5 Russia Biopharmaceutical CMO & CRO Revenue and Growth Rate (2013-2018)

6.6 Italy Biopharmaceutical CMO & CRO Revenue and Growth Rate (2013-2018)

7 Asia-Pacific Biopharmaceutical CMO & CRO Revenue by Countries

7.1 Asia-Pacific Biopharmaceutical CMO & CRO Revenue by Countries (2013-2018)

7.2 China Biopharmaceutical CMO & CRO Revenue and Growth Rate (2013-2018)

7.3 Japan Biopharmaceutical CMO & CRO Revenue and Growth Rate (2013-2018)

7.4 Korea Biopharmaceutical CMO & CRO Revenue and Growth Rate (2013-2018)

7.5 India Biopharmaceutical CMO & CRO Revenue and Growth Rate (2013-2018)

7.6 Southeast Asia Biopharmaceutical CMO & CRO Revenue and Growth Rate (2013-2018)

8 South America Biopharmaceutical CMO & CRO Revenue by Countries

8.1 South America Biopharmaceutical CMO & CRO Revenue by Countries (2013-2018)

8.2 Brazil Biopharmaceutical CMO & CRO Revenue and Growth Rate (2013-2018)

8.3 Argentina Biopharmaceutical CMO & CRO Revenue and Growth Rate (2013-2018)

8.4 Colombia Biopharmaceutical CMO & CRO Revenue and Growth Rate (2013-2018)

9 Middle East and Africa Revenue Biopharmaceutical CMO & CRO by Countries

9.1 Middle East and Africa Biopharmaceutical CMO & CRO Revenue by Countries (2013-2018)

9.2 Saudi Arabia Biopharmaceutical CMO & CRO Revenue and Growth Rate (2013-2018)

9.3 UAE Biopharmaceutical CMO & CRO Revenue and Growth Rate (2013-2018)

9.4 Egypt Biopharmaceutical CMO & CRO Revenue and Growth Rate (2013-2018)

9.5 Nigeria Biopharmaceutical CMO & CRO Revenue and Growth Rate (2013-2018)

9.6 South Africa Biopharmaceutical CMO & CRO Revenue and Growth Rate (2013-2018)

10 Global Biopharmaceutical CMO & CRO Market Segment by Type

10.1 Global Biopharmaceutical CMO & CRO Revenue and Market Share by Type (2013-2018)

10.2 Global Biopharmaceutical CMO & CRO Market Forecast by Type (2018-2023)

10.3 Mammalian Revenue Growth Rate (2013-2023)

10.4 Non-mammalian Revenue Growth Rate (2013-2023)

11 Global Biopharmaceutical CMO & CRO Market Segment by Application

11.1 Global Biopharmaceutical CMO & CRO Revenue Market Share by Application (2013-2018)

11.2 Biopharmaceutical CMO & CRO Market Forecast by Application (2018-2023)

11.3 Contract Manufacturing Revenue Growth (2013-2018)

11.4 Contract Research Revenue Growth (2013-2018)

12 Global Biopharmaceutical CMO & CRO Market Size Forecast (2018-2023)

12.1 Global Biopharmaceutical CMO & CRO Market Size Forecast (2018-2023)

12.2 Global Biopharmaceutical CMO & CRO Market Forecast by Regions (2018-2023)

12.3 North America Biopharmaceutical CMO & CRO Revenue Market Forecast (2018-2023)

12.4 Europe Biopharmaceutical CMO & CRO Revenue Market Forecast (2018-2023)

12.5 Asia-Pacific Biopharmaceutical CMO & CRO Revenue Market Forecast (2018-2023)

12.6 South America Biopharmaceutical CMO & CRO Revenue Market Forecast (2018-2023)

12.7 Middle East and Africa Biopharmaceutical CMO & CRO Revenue Market Forecast (2018-2023)

13 Research Findings and Conclusion

14 Appendix

14.1 Methodology

14.2 Data Source

版權(quán)聲明

?本報(bào)告所有內(nèi)容受法律保護(hù)，中華人民共和國涉外調(diào)查許可證：國統(tǒng)涉外證字第1454號。本報(bào)告由中商產(chǎn)業(yè)研究院出品，報(bào)告版權(quán)歸中商產(chǎn)業(yè)研究院所有。本報(bào)告是中商產(chǎn)業(yè)研究院的研究與統(tǒng)計(jì)成果，報(bào)告為有償提供給購買報(bào)告的客戶內(nèi)部使用。未獲得中商產(chǎn)業(yè)研究院書面授權(quán)，任何網(wǎng)站或媒體不得轉(zhuǎn)載或引用，否則中商產(chǎn)業(yè)研究院有權(quán)依法追究其法律責(zé)任。如需訂閱研究報(bào)告，請直接聯(lián)系本網(wǎng)站，以便獲得全程優(yōu)質(zhì)完善服務(wù)。本報(bào)告目錄與內(nèi)容系中商產(chǎn)業(yè)研究院原創(chuàng)，未經(jīng)本公司事先書面許可，拒絕任何方式復(fù)制、轉(zhuǎn)載。在此，我們誠意向您推薦鑒別咨詢公司實(shí)力的主要方法。